Retrospective analysis of effects of sodium-glucose co-transporter 2 inhibitor in Japanese type 2 diabetes mellitus patients with chronic kidney disease.

Kazuo KobayashiMasao ToyodaMoritsugu KimuraNobuo HatoriTakayuki FurukiHiroyuki SakaiMasahiro TakihataTomoya UmezonoShun ItoDaisuke SuzukiHiroshi TakedaAkira KanamoriHisakazu DegawaHareaki YamamotoHideo MachimuraAtsuko MokuboKeiichi ChinMitsuo ObanaToshimasa HishikiKouta AoyamaShinichi NakajimaShinichi UmezawaHidetoshi ShimuraTogo AoyamaKazuyoshi SatoMasaaki Miyakawa

Published in: Diabetes & vascular disease research (2018)

This study confirmed that the beneficial renal effects of SGLT2 inhibitor in Japanese type 2 diabetes mellitus patients with chronic kidney disease, similar to those reported in large-scale clinical trials conducted in Western countries.

Keyphrases

clinical trial
glycemic control
cardiovascular risk factors
south africa
type diabetes
cardiovascular disease
adipose tissue
insulin resistance
weight loss
study protocol
placebo controlled